ImmunityBio

2.08
-0.01
-0.48%
IBRX
高 2.14开 2.09量 4169.24万股总市值 20.49亿
低 2.00换 4.23%额 8574.66万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
ImmunityBio(IBRX)
12-17 07:05  
$ImmunityBio(IBRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001364846-25-000006  Size: 401 KB 网页链接
用户头像
ImmunityBio(IBRX)
12-17 07:05  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001364846-25-000007  Size: 6 KB 网页链接
用户头像
ImmunityBio(IBRX)
12-16 05:55  
$ImmunityBio(IBRX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001326110-25-000146  Act: 34  Size: 150 KB 网页链接
用户头像
ImmunityBio(IBRX)
12-12 20:05  
$ImmunityBio(IBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001326110-25-000143  Act: 34  Size: 219 KB 网页链接
用户头像
ImmunityBio(IBRX)
11-11 08:45  
$ImmunityBio(IBRX)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-274843  Act: 34  Size: 21 KB 网页链接
用户头像
ImmunityBio(IBRX)
11-05 19:15  
$ImmunityBio(IBRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001326110-25-000138  Act: 34  Size: 297 KB 网页链接
用户头像
ImmunityBio(IBRX)
11-05 19:15  
$ImmunityBio(IBRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001326110-25-000139  Act: 34  Size: 16 MB 网页链接
用户头像
ImmunityBio(IBRX)
10-21 05:35  
$ImmunityBio(IBRX)$ DEF 14C Other definitive information statements Accession Number: 0001326110-25-000129  Act: 34  Size: 175 KB 网页链接
用户头像
ImmunityBio(IBRX)
10-09 05:05  
$ImmunityBio(IBRX)$ PRE 14C Other preliminary information statements Accession Number: 0001326110-25-000124  Act: 34  Size: 174 KB 网页链接
用户头像
ImmunityBio(IBRX)
08-09 04:35  
$ImmunityBio(IBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-177024  Act: 34  Size: 641 KB 网页链接
用户头像
ImmunityBio(IBRX)
08-05 19:45  
$ImmunityBio(IBRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001326110-25-000114  Act: 34  Size: 15 MB 网页链接
用户头像
ImmunityBio(IBRX)
08-05 19:25  
$ImmunityBio(IBRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001326110-25-000112  Act: 34  Size: 299 KB 网页链接
用户头像
ImmunityBio(IBRX)
07-28 23:15  
$ImmunityBio(IBRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-165807  Act: 33  Size: 916 KB 网页链接
用户头像
ImmunityBio(IBRX)
07-25 18:25  
$ImmunityBio(IBRX)$ 8-K Current report, items 1.01, 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-164789  Act: 34  Size: 764 KB 网页链接
1赞
用户头像
ImmunityBio(IBRX)
06-24 05:15  
$ImmunityBio(IBRX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001326110-25-000099  Act: 33  Size: 273 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:45  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000094  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:45  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000093  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:45  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000092  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:35  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000090  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:35  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000091  Size: 5 KB 网页链接